Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Prevalence and Genotype Distribution of Human Papillomavirus in Cheonan, Korea

  • Kim, Jae Kyung (Department of Laboratory Medicine, Dankook University Hospital) ;
  • Jeon, Jae-Sik (Department of Laboratory Medicine, Dankook University College of Medicine) ;
  • Lee, Chong Heon (Department of Oral Pathology, College of Dentistry, Dankook University) ;
  • Kim, Jong Wan (Department of Laboratory Medicine, Dankook University College of Medicine)
  • Received : 2014.05.08
  • Accepted : 2014.05.27
  • Published : 2014.08.28
Download PDF
⟨ Previous Next ⟩

Abstract

Human papillomavirus (HPV) infection is considered to play a critical role in the development of cervical carcinoma, which is the third most common cancer among Korean females. Here, we performed a baseline study of HPV infection and genotyping using an HPV DNA chip, which is a type of oligonucleotide microarray. A total of 6,855 cervical swab specimens from 5,494 women attending Dankook University Hospital Health Improvement Center in Cheonan, Korea between 2006 and 2012, originally collected for HPV infection screening, were genotyped for HPV. The extracted DNA from the cervical specimens was investigated by an HPV DNA chip designed to detect 41 different HPV types. HPV was identified as positive in 1,143 (16.7%) of the 6,855 samples. The most frequently detected HPV genotypes were HPV types 16, 53, 56, 58, 39, 52, 70, 84, 68, 62, 35, 54, 81, 18, and 30, in descending order of incidence. The proportions of single and multiple HPV infections in the HPV-positive specimens were 78.1% and 21.9%, respectively. The average age of HPV-positive patients was 39.9 years, with the positive rate of HPV being the highest in the 10-29 age group (20.6%). We report here on the prevalence and distribution of 41 different genotypes of HPV according to age among women in Cheonan, Korea. These data may be of use as baseline data for the assessment of public health-related issues and for the development of area-specific HPV vaccines.

Keywords

References

  1. An HJ, Cho NH, Lee SY, Kim IH, Lee C, Kim SJ, et al. 2003. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 97: 1672-1680. https://doi.org/10.1002/cncr.11235
  2. Baudu A, Prétet JL, Riethmuller D, Chotard M, Mougin C, Mercier M. 2014. Prevalence and risk factors of human papillomavirus infection types 16/18/45 in a cohort of French females aged 15-23 years. J. Epidemiol. Glob. Health 4: 35-43. https://doi.org/10.1016/j.jegh.2013.11.003
  3. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, et al. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 87: 796-802. https://doi.org/10.1093/jnci/87.11.796
  4. Castellsague X, Diaz M, de Sanjose S, Munoz N, Herrero R, Franceschi S, et al. 2006. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J. Natl. Cancer Inst. 98: 303-315. https://doi.org/10.1093/jnci/djj067
  5. Chen Q, Xie LX, Qing ZR, Li LJ, Luo ZY, Lin M, et al. 2012. Epidemiologic characterization of human papillomavirus infection in rural Chaozhou, eastern Guangdong Province of China. PLoS One 7: e32149. https://doi.org/10.1371/journal.pone.0032149
  6. Cho NH, An HJ, Jeong JK, Kang S, Kim JW, Kim YT, et al. 2003. Genotyping of 22 human papillomavirus types by DNA chip in Korean women: comparison with cytologic diagnosis. Am. J. Obstet. Gynecol. 188: 56-62. https://doi.org/10.1067/mob.2003.120
  7. Chung S, Shin S, Yoon JH, Roh EY, Seoung SJ, Kim GP, et al. 2013. Prevalence and genotype of human papillomavirus infection and risk of cervical dysplasia among asymptomatic Korean women. Ann. Clin. Microbiol. 16: 87-91. https://doi.org/10.5145/ACM.2013.16.2.87
  8. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. 2003. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88: 63-73. https://doi.org/10.1038/sj.bjc.6600688
  9. De Vuyst H, Parisi MR, Karani A, Mandaliya K, Muchiri L, Vaccarella S, et al. 2010. The prevalence of human papillomavirus infection in Mombasa, Kenya. Cancer Causes Control 21: 2309-2313. https://doi.org/10.1007/s10552-010-9645-z
  10. Estrade C, Menoud PA, Nardelli-Haefliger D, Sahli R. 2011. Validation of a low-cost human papillomavirus genotyping assay based on PGMY PCR and reverse blotting hybridization with reusable membranes. J. Clin. Microbiol. 49: 3474-3481. https://doi.org/10.1128/JCM.05039-11
  11. Gargiulo F, De Francesco MA, Schreiber C, Ciravolo G, Salinaro F, Valloncini B, et al. 2007. Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women. Virus Res. 125: 176-182. https://doi.org/10.1016/j.virusres.2006.12.017
  12. Grahovac M, Raciæ I, Hadzisejdiæ I, Doriæ A, Grahovac B. 2007. Prevalence of human papillomavirus among Croatian women attending regular gynecological visit. Coll. Antropol. 31 (Suppl 2): 73-77.
  13. Grinsztejn B, Veloso VG, Levi JE, Velasque L, Luz PM, Friedman RK, et al. 2009. Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women. Int. J. Infect. Dis. 13: 72-80. https://doi.org/10.1016/j.ijid.2008.03.031
  14. Hwang HS, Park M, Lee SY, Kwon KH, Pang MG. 2004. Distribution and prevalence of human papillomavirus genotypes in routine pap smear of 2,470 Korean women determined by DNA chip. Cancer Epidemiol. Biomarkers Prev. 13: 2153-2156.
  15. Kim YT. 2009. Current status of cervical cancer and HPV infection in Korea. J. Gynecol. Oncol. 20: 1-7. https://doi.org/10.3802/jgo.2009.20.1.1
  16. Kim HW. 2012. Knowledge about human papillomavirus (HPV), and health beliefs and intention to recommend HPV vaccination for girls and boys among Korean health teachers. Vaccine 30: 5327-5334. https://doi.org/10.1016/j.vaccine.2012.06.040
  17. Kim Y J, Kwon MJ, Woo HY, Paik SY. 2013. P revalence of human papillomavirus infection and genotype distribution determined by the cyclic-catcher melting temperature analysis in Korean medical checkup population. J. Microbiol. 51: 665-670. https://doi.org/10.1007/s12275-013-3160-3
  18. Lee GH, Kang HJ, K im SY, Park CM. 2011. The p revalence of human papilloma virus infections according to Pap smear results in Jeju island. Korean J. Obstet. Gynecol. 54: 689-695. https://doi.org/10.5468/KJOG.2011.54.11.689
  19. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348: 518-527. https://doi.org/10.1056/NEJMoa021641
  20. Nygard M, Hansen BT, Dillner J, Munk C, Oddsson K, Tryggvadottir L, et al. 2014. Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance. PLoS One 9: e88323. https://doi.org/10.1371/journal.pone.0088323
  21. Nyitray AG, Iannacone MR. 2014. The epidemiology of human papillomaviruses. Curr. Probl. Dermatol. 45: 75-91. https://doi.org/10.1159/000358370
  22. Schiffman M, Adrianza ME. 2000. ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol. 44: 726-742. https://doi.org/10.1159/000328554
  23. Seol HJ, Ki KD, Lee JM. 2014. Epidemiologic characteristics of cervical cancer in Korean women. J. Gynecol. Oncol. 25: 70-74. https://doi.org/10.3802/jgo.2014.25.1.70
  24. Shin E, Bae H, Song WK, Jung SK, Hwang YS. 2013. Comparative evaluation of the HPV28 detection and HPV DNA Chip Test for detecting and genotyping human papillomaviruses. Lab. Med. Online 3: 234-241. https://doi.org/10.3343/lmo.2013.3.4.234
  25. Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, et al. 2003. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int. J. Cancer 103: 413-421. https://doi.org/10.1002/ijc.10825
  26. Vidal AC, Murphy SK, Hernandez BY, Vasquez B, Bartlett JA, Oneko O, et al. 2011. Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women. Infect. Agent. Cancer 6: 20. https://doi.org/10.1186/1750-9378-6-20
  27. Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE. 2009. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J. Natl. Cancer Inst. 101: 475-487. https://doi.org/10.1093/jnci/djn510

Cited by

  1. Identification of human papillomavirus as a preventive strategy for cervical cancer in asymptomatic women in the Peruvian Andes vol.7, pp.suppl1, 2014, https://doi.org/10.1016/s1995-7645(14)60217-0
  2. Human Papillomavirus Genotype Distribution Among 18,815 Women in 13 Korean Cities and Relationship With Cervical Cytology Findings vol.37, pp.5, 2014, https://doi.org/10.3343/alm.2017.37.5.426
  3. Human Papilloma Virus Genotype Distribution in Cervical lesions in Zanjan, Iran vol.18, pp.12, 2017, https://doi.org/10.22034/apjcp.2017.18.12.3373
  4. Prevalence of Human Papillomavirus Infection and Genotype Distribution Determined via Real-Time PCR in a Korean Medical Check-up Population vol.46, pp.2, 2014, https://doi.org/10.4014/mbl.1803.03006
  5. Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea vol.7, pp.None, 2014, https://doi.org/10.1016/j.pvr.2018.12.002